Pharma/Biotech - Page 163 | TalkMarkets

Content

All Posts > Content under Pharma/Biotech
2593 to 2608 of 5463 Posts
<<< 1 ... 161 162 163 164 165 ... 342 >>>
Cannabis Central: Only 2 ETFs Provide Exclusive Exposure To U.S. Marijuana Multi-State Operators
Article By: Lorimer Wilson
Monday, August 12, 2019 11:27 AM EDT
Marijuana cultivation is legal in 33 American states but remains federally illegal so U.S. companies in the business can't list their securities on U.S. stock exchanges so many such companies are listing their stocks on Canadian stock exchanges.
Read
Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma
Article By: ChinaBio® Today
Saturday, August 10, 2019 6:05 PM EDT
Nanjing King-Friend Bio invested $95 million in Meitheal Pharma of Chicago, a generic injectables company, raising its holdings to a majority stake.
In this article: GILD
Read
Cannabis Central: These Marijuana- Related Companies Pay Dividends
Article By: Lorimer Wilson
Friday, August 9, 2019 3:44 AM EDT
Several consumer goods & biopharmaceutical companies have ventured into the marijuana space but continue to generate the majority of their revenues and earnings in their primary business.
In this article: CODI, MO, ABBV, ACNFF, IMBBY, NVS, TAP, BUD, SMG, STZ, IIPR, ASBFY Also: CRON, HEXO, TLRY
Read
August Would Be A Wonderful Month For A Market Correction
Article By: David Moadel
Sunday, August 4, 2019 5:35 PM EDT
I'm feeling sadistic. Will the market go ballistic?
In this article: LEG, SO Also: SPY, SPX, ADM, QCOM, WBA
Read
IPO Outlook For The Week: Beauty Treatments, Banking And Liver Therapy
Article By: Benzinga
Sunday, August 4, 2019 9:18 AM EDT
Our latest on AMTD International Inc., Biovie Inc., and Inmode Ltd.
In this article: BIVI, INMD, KHIB
Read
Week In Review: United Healthcare, A China Hospital Chain, Acquired For $1.4 Billion
Article By: ChinaBio® Today
Saturday, August 3, 2019 5:22 PM EDT
This week in deals and financing, United Family Healthcare, a China hospital chain, will be acquired by New Frontier Corp from TPG and Fosun Pharma at an expected value of $1.44 billion.
Read
Cannabis Central: 9 Major Consumer Products & Pharmaceutical Corporations Now Invested In Marijuana Companies
Article By: Lorimer Wilson
Friday, August 2, 2019 2:00 PM EDT
Conservative investors who want to invest in marijuana stocks might be better served by investing in the above mentioned major corporations than in any individual cannabis company.
In this article: BUD, MO, NVS, STZ, TAP, CGC, CRON, TLRY, PYX, HEXO
Read
New Tariff Threat Ends Rebound Rally
Article By: Zacks Investment Research
Friday, August 2, 2019 12:18 PM EDT
We were on our way to recovering all of yesterday’s selloff in Thursday’s session, but a curve-ball on trade ended the rally and gave us another day of losses, as Trump announced more tariffs on China. Plus today's portfolio highlights..
In this article: CAR, SPWR, META, GWPH, RUBI, AYX
Read
Gaia Grow Corp.: ~1,494 Acres Of Hemp Planted In Canada, First Harvest In ~ 2 Months
Article By: Peter Epstein
Thursday, August 1, 2019 7:15 PM EDT
Gaia Grow Corp. began trading on August 1st. The company has a C$20 M market cap. It has 1,494 acres of hemp growing in southern Alberta. Harvest expected in about 2 months. If harvest is successful, the company will be off to the races.
Read
Atara: The Silver Bullet For Multiple Sclerosis
Article By: Dr. Hung Tran
Thursday, August 1, 2019 12:05 AM EDT
The firm will report Phase 3 results for its lead franchise tab-cell this year. The positive outcomes will erase doubt and fear regarding the departure of senior management.
In this article: ATRA
Read
Humana's (HUM) Earnings And Revenues Beat Estimates In Q2
Article By: Zacks Investment Research
Wednesday, July 31, 2019 1:16 PM EDT
Humana Inc.’s second-quarter 2019 operating earnings per share of $6.05 beat the Zacks Consensus Estimate by 15.5%.
In this article: HUM
Read
Pfizer Slides As Analysts Move To Sidelines Following Mylan Deal Guidance Cut
Article By: The Fly
Tuesday, July 30, 2019 1:39 PM EDT
Shares of Pfizer are under pressure after both Morgan Stanley and Bank of America Merrill Lynch downgraded the stock to Neutral-equivalent ratings.
In this article: PFE Also: MYL
Read
Cannabis Central: Dismal Month For Every "Pot" Stock & ETF Except Neptune Wellness Solutions Inc.
Article By: Lorimer Wilson
Tuesday, July 30, 2019 12:56 PM EDT
Neptune operates as a nutrition supplement company that develops and produces cannabis products, marine and seed oils and pet supplements for clients in Canada. It is a small-cap stock ($705M) with a current beta of 1.57.
In this article: NEPT Also: CRON, CBWTF, CURLF, IMBBF, HERTF, CTABF
Read
Exact Sciences Is Going Higher
Article By: Quad 7 Capital
Tuesday, July 30, 2019 12:23 PM EDT
With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.
In this article: EXAS, GHDX Also: PFE
Read
Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes And Reverse Stock Split
Article By: NASDAQ GlobeNewswire
Tuesday, July 30, 2019 12:16 AM EDT
Plus Therapeutics, Inc. today announced that the Company has officially changed its name from “Cytori Therapeutics, Inc.” to “Plus Therapeutics, Inc.” and the ticker symbol will change from “CYTX” to “PSTV”.
In this article: PSTV
Read
Healthcare (Top 30 Weights) Earnings Estimates/Revisions
Article By: T.J. Hayes
Monday, July 29, 2019 2:59 PM EDT
Estimates for the Healthcare sector have been revised up by 1.13% in the past 70 days.
In this article: XLV
Read
2593 to 2608 of 5463 Posts
<<< 1 ... 161 162 163 164 165 ... 342 >>>